Low high-density lipoprotein cholesterol levels predicting poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure

BackgroundLipid profile disorders frequently occur in patients with advanced liver diseases. High-density lipoprotein cholesterol (HDL-C) levels decrease rapidly during acute conditions of some diseases, and HDL-C levels may be related to mortality in patients with hepatitis B virus-related acute-on...

Full description

Bibliographic Details
Main Authors: Yue Zhang, Peng Chen, Yun Zhang, Yuan Nie, Xuan Zhu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.1001411/full
_version_ 1811186689028128768
author Yue Zhang
Peng Chen
Yun Zhang
Yuan Nie
Xuan Zhu
author_facet Yue Zhang
Peng Chen
Yun Zhang
Yuan Nie
Xuan Zhu
author_sort Yue Zhang
collection DOAJ
description BackgroundLipid profile disorders frequently occur in patients with advanced liver diseases. High-density lipoprotein cholesterol (HDL-C) levels decrease rapidly during acute conditions of some diseases, and HDL-C levels may be related to mortality in patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF).Materials and methodsA retrospective cohort study was conducted on 200 subjects with HBV-ACLF. The patients were separated into non-survivors and survivors according to their 28-day outcome. Univariate and multivariate Cox regression analyses were performed to identify predictors of mortality, and the performance of these predictors was evaluated by receiver operating characteristic (ROC) curve analysis. Kaplan–Meier analysis was performed to draw survival curves of HDL-C.ResultsThe 28-day mortality in the cohort was 27.0%. HDL-C levels differed markedly between non-survivors and survivors. In the multivariate analysis, HDL-C, the Child-Turcotte-Pugh (CTP), model for end-stage liver disease (MELD), and Chinese Group on the Study of Severe Hepatitis B-ACLF II (COSSH-ACLF II) scores were identified as independent predictors for mortality (HR = 0.806, 95% CI: 0.724–0.898; HR = 1.424, 95% CI: 1.143–1.775; HR = 1.006, 95% CI: 1.002–1.007; and HR = 1.609, 95% CI: 1.005–2.575, respectively). Patients with lower HDL-C levels had a worse prognosis than those with higher HDL-C levels. In ROC analysis, the prognostic accuracy for mortality was similar between HDL-C (AUROC: 0.733) and the CTP, MELD, and COSSH-ACLF II scores (AUROC: 0.753; 0.674 and 0.770, respectively).ConclusionThe HDL-C level may serve as a potential indicator for the prognosis of HBV-ACLF and can be used as a simple marker for risk assessment and selection of therapeutic options.
first_indexed 2024-04-11T13:49:23Z
format Article
id doaj.art-8baf09e90f9042089e68dcd4b1a5c7b9
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-04-11T13:49:23Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-8baf09e90f9042089e68dcd4b1a5c7b92022-12-22T04:20:43ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-11-01910.3389/fmed.2022.10014111001411Low high-density lipoprotein cholesterol levels predicting poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failureYue ZhangPeng ChenYun ZhangYuan NieXuan ZhuBackgroundLipid profile disorders frequently occur in patients with advanced liver diseases. High-density lipoprotein cholesterol (HDL-C) levels decrease rapidly during acute conditions of some diseases, and HDL-C levels may be related to mortality in patients with hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF).Materials and methodsA retrospective cohort study was conducted on 200 subjects with HBV-ACLF. The patients were separated into non-survivors and survivors according to their 28-day outcome. Univariate and multivariate Cox regression analyses were performed to identify predictors of mortality, and the performance of these predictors was evaluated by receiver operating characteristic (ROC) curve analysis. Kaplan–Meier analysis was performed to draw survival curves of HDL-C.ResultsThe 28-day mortality in the cohort was 27.0%. HDL-C levels differed markedly between non-survivors and survivors. In the multivariate analysis, HDL-C, the Child-Turcotte-Pugh (CTP), model for end-stage liver disease (MELD), and Chinese Group on the Study of Severe Hepatitis B-ACLF II (COSSH-ACLF II) scores were identified as independent predictors for mortality (HR = 0.806, 95% CI: 0.724–0.898; HR = 1.424, 95% CI: 1.143–1.775; HR = 1.006, 95% CI: 1.002–1.007; and HR = 1.609, 95% CI: 1.005–2.575, respectively). Patients with lower HDL-C levels had a worse prognosis than those with higher HDL-C levels. In ROC analysis, the prognostic accuracy for mortality was similar between HDL-C (AUROC: 0.733) and the CTP, MELD, and COSSH-ACLF II scores (AUROC: 0.753; 0.674 and 0.770, respectively).ConclusionThe HDL-C level may serve as a potential indicator for the prognosis of HBV-ACLF and can be used as a simple marker for risk assessment and selection of therapeutic options.https://www.frontiersin.org/articles/10.3389/fmed.2022.1001411/fullhigh-density lipoprotein cholesterolhepatitis B virusacute-on-chronic liver failureprognosisCTP scoreMELD score
spellingShingle Yue Zhang
Peng Chen
Yun Zhang
Yuan Nie
Xuan Zhu
Low high-density lipoprotein cholesterol levels predicting poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure
Frontiers in Medicine
high-density lipoprotein cholesterol
hepatitis B virus
acute-on-chronic liver failure
prognosis
CTP score
MELD score
title Low high-density lipoprotein cholesterol levels predicting poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure
title_full Low high-density lipoprotein cholesterol levels predicting poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure
title_fullStr Low high-density lipoprotein cholesterol levels predicting poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure
title_full_unstemmed Low high-density lipoprotein cholesterol levels predicting poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure
title_short Low high-density lipoprotein cholesterol levels predicting poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure
title_sort low high density lipoprotein cholesterol levels predicting poor outcomes in patients with hepatitis b virus related acute on chronic liver failure
topic high-density lipoprotein cholesterol
hepatitis B virus
acute-on-chronic liver failure
prognosis
CTP score
MELD score
url https://www.frontiersin.org/articles/10.3389/fmed.2022.1001411/full
work_keys_str_mv AT yuezhang lowhighdensitylipoproteincholesterollevelspredictingpooroutcomesinpatientswithhepatitisbvirusrelatedacuteonchronicliverfailure
AT pengchen lowhighdensitylipoproteincholesterollevelspredictingpooroutcomesinpatientswithhepatitisbvirusrelatedacuteonchronicliverfailure
AT yunzhang lowhighdensitylipoproteincholesterollevelspredictingpooroutcomesinpatientswithhepatitisbvirusrelatedacuteonchronicliverfailure
AT yuannie lowhighdensitylipoproteincholesterollevelspredictingpooroutcomesinpatientswithhepatitisbvirusrelatedacuteonchronicliverfailure
AT xuanzhu lowhighdensitylipoproteincholesterollevelspredictingpooroutcomesinpatientswithhepatitisbvirusrelatedacuteonchronicliverfailure